These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14361459)

  • 1. The fate of tubercle bacilli in vivo.
    HOBBY GL
    Am J Med; 1955 May; 18(5):753-63. PubMed ID: 14361459
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical significance of positive cultures and of isoniazid-resistant tubercle bacilli during the treatment of pulmonary tuberculosis; report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council.
    FOX W; SUTHERLAND I
    Thorax; 1955 Jun; 10(2):85-98. PubMed ID: 14396842
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cultural detection of tubercle bacilli in negative microscopic material (sputum); pseudonegativity in chemotherapy of pulmonary tuberculosis].
    SCHAUB R
    Tuberkulosearzt; 1954 Nov; 8(11):685-92. PubMed ID: 14359491
    [No Abstract]   [Full Text] [Related]  

  • 4. The treated pulmonary lesion and its tubercle bacillus. II. The death and resurrection.
    VANDIVIERE HM; LORING WE; MELVIN I; WILLIS S
    Am J Med Sci; 1956 Jul; 232(1):30-7; passim. PubMed ID: 13326887
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of the effect of conteben on the tubercle bacillus; the effect of conteben therapy upon the morphology and virulence of tubercle bacilli present in the sputum].
    BIENENGRABER A; URBACH H
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(1):68-82. PubMed ID: 14820743
    [No Abstract]   [Full Text] [Related]  

  • 6. A serial investigation on the effect of tubercle endotoxoid in pulmonary tuberculosis.
    SALINGER PL
    S Afr Med J; 1946 Jul; 20():375-84. PubMed ID: 20993965
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vivo relationship between 1314Th resistance and thiosemicarbazone resistance of tubercle bacilli in patients].
    TSUKAMURA M
    Kekkaku; 1962 Feb; 37():103-6. PubMed ID: 13922911
    [No Abstract]   [Full Text] [Related]  

  • 8. The recovery of streptomycin sensitive tubercle bacilli from a patient with pulmonary tuberculosis who had previously yielded highly resistant bacilli.
    MITCHELL RS; WOLINSKY E; STEENKEN W
    Ann Intern Med; 1952 May; 36(5):1309-17. PubMed ID: 14924464
    [No Abstract]   [Full Text] [Related]  

  • 9. Streptomycin para-aminosalicylate and streptomycin resistant tubercle bacilli.
    ADCOCK JD; FIDLER WF; MEIER WA; OWEN CR
    Am J Med Sci; 1951 Feb; 221(2):149-51. PubMed ID: 14799477
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE RELATIONSHIP OF CHANGES IN THE AMOUNT OF DISCHARGED TUBERCLE BACILLI TO ITS DRUG RESISTANCE. A STUDY OF SIGNIFICANCE OF THE RESISTANCE TEST IN CASES WHICH DISCHARGE TUBERCLE BACILLI SLIGHTLY].
    HAGIHARA T; OKAYASU M; KAWAMURA A; OGAWA M
    Kekkaku; 1964 Dec; 39():532-6. PubMed ID: 14270665
    [No Abstract]   [Full Text] [Related]  

  • 11. Spread of infection by streptomycin-resistant tubercle bacilli.
    HAROLD JT
    Lancet; 1951 Oct; 2(6685):658-63. PubMed ID: 14874473
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical studies on the alpha-ethyl-thioisonicotinamide (1314Th) resistance of tubercle bacilli, with special regard to the resistance test by direct method and the mode of development of resistance].
    TSUKAMURA M; ABO T
    Kekkaku; 1961 Jun; 336():361-5. PubMed ID: 13778438
    [No Abstract]   [Full Text] [Related]  

  • 13. [Paraaminosalicylic acid in the TB. pulmonary].
    BARDESONO G
    Minerva Med; 1949 Jan; 40(5):131-3. PubMed ID: 18115408
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavior of the Koch bacillus in isoniazide therapy; isoniazide-resistance and isoniazide-dependence].
    REALE M; GARAVENTA A; GHIONE M
    Minerva Med; 1952 Sep; 43(74):396-400. PubMed ID: 13012977
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on problems of virulence and resistance of tubercle bacterial strains from pulmonary tuberculosis patients after chemotherapy].
    GIERHAKE FW
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1954; 112(4):283-92. PubMed ID: 13219069
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on tubercle bacilli and their contaminant bacteria in the sputum of pulmonary tuberculosis after chemotherapy ].
    Sakai I
    Hokkaido Igaku Zasshi; 1982 Mar; 57(2):211-6. PubMed ID: 6811390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in the drug resistance of tubercle bacilli before and after chemotherapy of pulmonary tuberculosis].
    OKUBO H
    Kekkaku; 1961 Nov; 36():712-9. PubMed ID: 14481598
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sensitivity and resistance of Koch bacilli to isoniazide during therapy].
    PIECHAUD F; NAPPEE J
    J Med Bord; 1952 Oct; 129(10):954-5. PubMed ID: 13023192
    [No Abstract]   [Full Text] [Related]  

  • 19. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy.
    MCCUNE RM; TOMPSETT R
    J Exp Med; 1956 Nov; 104(5):737-62. PubMed ID: 13367341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The attitude of tubercle bacilli in sputum, especially on the smear positive and culture negative cases. I. Changes of the daily number of tubercle bacilli in sputum by chemotherapy].
    NISHIMURA H
    Kekkaku; 1956 Apr; 31(4):222-7. PubMed ID: 13320645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.